S. Constantine

672 citations

27 papers · 477 indexed · h-index 9

Impact in

Dermatology top 10%
Pulmonary and Respiratory Medicine top 10%
- Cystic Fibrosis Research Advances
- Neonatal Respiratory Health Research
- Tracheal and airway disorders
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Papers in ⓘ

Dermatology 5
- Skin Diseases and Diabetes 3
Pulmonary and Respiratory Medicine 11
- Cystic Fibrosis Research Advances 7
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 3
- Inhalation and Respiratory Drug Delivery 3
- Respiratory and Cough-Related Research 3

Co-authors: Barbara White (14 shared papers)Nancy Dgetluck (11 shared papers)Gary Elfring (5 shared papers)Temitayo Ajayi (3 shared papers)K. De Boeck (3 shared papers)Isabelle Sermet‐Gaudelus (3 shared papers)Samit Hirawat (4 shared papers)A. Reha (3 shared papers)
Journals: Annals of the Rheumatic Diseases (9 papers)Journal of Cystic Fibrosis (7 papers)Journal of Investigative Dermatology (3 papers)BMC Infectious Diseases (1 paper)Arthritis & Rheumatology (1 paper)
Partner nations: United States United Kingdom Sri Lanka

In The Last Decade

S. Constantine

24 papers receiving 467 citations

Peers

Countries citing papers authored by S. Constantine

Since Specialization

Citations

This map shows the geographic impact of S. Constantine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Constantine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Constantine more than expected).

Fields of papers citing papers by S. Constantine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Constantine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Constantine. The network helps show where S. Constantine may publish in the future.

Co-authors

The 25 scholars most cited alongside S. Constantine, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S. Constantine Line = papers co-authored together S. Constantine links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Ataluren (PTC124) Induces Cystic Fibrosis Transmembrane Conductance Regulator Protein Expression and Activity in Children with Nonsense Mutation Cystic Fibrosis American Journal of Respiratory and Critical Care Medicine ·Isabelle Sermet‐Gaudelus, K. De Boeck, Georges Casimir, F. Vermeulen, Teresinha Leal, Agnès Mogenet, Delphine Roussel, Janine Fritsch, L. Hanssens, Samit Hirawat, Nilsen L. Miller, S. Constantine, A. Reha, Temitayo Ajayi, Gary Elfring, Langdon L. Miller	2010	184
2	Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo‐Controlled Trial in Adults With Systemic Sclerosis Arthritis & Rheumatology ·Robert Spiera, Laura K. Hummers, Leland W.K. Chung, Tracy Frech, Robyn T. Domsic, Vivien Hsu, Daniel E. Furst, Jessica Gordon, Maureen D. Mayes, Robert W. Simms, Robert Lafyatis, Viktor Martyanov, Tammara Wood, Michael L. Whitfield, S. Constantine, Elizabeth Lee, Nancy Dgetluck, Barbara White	2020	72
3	Safety and efficacy of lenabasum in a phase 2 randomized, placebo-controlled trial in adults with cystic fibrosis Journal of Cystic Fibrosis ·James F. Chmiel, Patrick A. Flume, D.G. Downey, Allen J. Dozor, Carla Colombo, Henryk Mazurek, Ewa Sapiejka, Marta Rachel, S. Constantine, Brian Conley, Nancy Dgetluck, Quinn Dinh, Barbara White, J.S. Elborn	2020	58
4	Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: A Randomized Clinical Trial Journal of Investigative Dermatology ·Victoria P. Werth, Emily Z. Hejazi, S.M. Peña, Jessica S. Haber, Majid Zeidi, Nithin Reddy, Joyce Okawa, Rui Feng, Muhammad M. Bashir, Kirubel Gebre, Arvin Jadoo, Josef Symon S. Concha, Nancy Dgetluck, S. Constantine, Barbara White	2022	37
5	FRI0470 A phase 2 study of safety and efficacy of lenabasum (JBT-101), a cannabinoid receptor type 2 agonist, in refractory skin-predominant dermatomyositis Annals of the Rheumatic Diseases ·Victoria P. Werth, Emily Z. Hejazi, S.M. Peña, J Háber, Joyce Okawa, Ru Feng, K. Gabre, Josef Concha, C. Cornwall, Nancy Dgetluck, S. Constantine, Barbara White	2018	16
6	Ambulatory quantitative waking and sleeping cough assessment in patients with cystic fibrosis Journal of Cystic Fibrosis ·Eitan Kerem, Michael Wilschanski, Nilsen L. Miller, Thea Pugatsch, Tali Cohen, Hannah Blau, Joseph Rivlin, David Shoseyov, A. Reha, S. Constantine, Temitayo Ajayi, Samit Hirawat, Gary Elfring, Stuart W. Peltz, Langdon L. Miller	2011	11
7	OP0126 A phase 2 study of safety and efficacy of anabasum (JBT-101) in systemic sclerosis Annals of the Rheumatic Diseases ·Robert Spiera, Laura K. Hummers, Leland W.K. Chung, Tracy Frech, Robyn T. Domsic, Daniel E. Fürst, Jessica Gordon, Maureen D. Mayes, Robert W. Simms, S. Constantine, Barbara White	2017	11
8	SAT0512 Safety and efficacy of lenabasum in refractory skin-predominant dermatomyositis subjects treated in an open label extension of trial jbt101-dm-001 Annals of the Rheumatic Diseases ·Victoria P. Werth, Basil Patel, Josef Concha, Joyce Okawa, David R. Pearson, Emily Z. Hejazi, Ruofei Feng, C. Cornwall, Nancy Dgetluck, S. Constantine, Arun Aggarwal, Barbara White	2018	8
9	OP0171 PHASE 3 TRIAL OF LENABASUM, A CB2 AGONIST, FOR THE TREATMENT OF DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS (DCSSC) Annals of the Rheumatic Diseases ·Robert Spiera, Masataka Kuwana, Dinesh Khanna, Laura K. Hummers, Tracy Frech, Wendy Stevens, Jessica Gordon, Suzanne Kafaja, Marco Matucci‐Cerinic, Oliver Distler, E. B. Lee, Yael Levy, Jae‐Bum Jun, S. Constantine, Nancy Dgetluck, Barbara White, D. Furst, Christopher P. Denton	2021	8
10	PTC124 induces CFTR full-length production and activity in children with nonsense-mutation-mediated CF Journal of Cystic Fibrosis ·Isabelle Sermet‐Gaudelus, Teresinha Leal, K. De Boeck, Georges Casimir, L. Hanssens, Pedro Antônio Mufarrej Hage, Delphine Roussel, A. Mogenet, Samit Hirawat, Gary Elfring, S. Constantine, L.L. Miller	2008	8
11	WS01.5 A Phase 2 study of the safety, pharmacokinetics, and efficacy of anabasum (JBT-101) in cystic fibrosis (CF) Journal of Cystic Fibrosis ·James F. Chmiel, J.S. Elborn, S. Constantine, Barbara White	2017	8
12	Disseminated Mycobacterium simiae infection in a patient with adult-onset immunodeficiency due to anti-interferon-gamma antibodies – a case report BMC Infectious Diseases ·B. S. D. P. Keragala, C. N. Gunasekera, Paul Devakar Yesudian, Chandima Guruge, B. S. Dissanayaka, D. P. Liyanagama, G. I. M. Jinadasa, S. Constantine, H. M. M. T. B. Herath	2020	7
13	SAT0303 DESIGN OF PHASE 3 STUDY OF LENABASUM FOR THE TREATMENT OF DERMATOMYOSITIS Annals of the Rheumatic Diseases ·Victoria P. Werth, Chester V. Oddis, Ingrid E. Lundberg, David Fiorentino, C. Cornwall, Nancy Dgetluck, S. Constantine, Barbara White	2019	7
14	65 Phase 3 study of ataluren (PTC124®) in nonsense mutation cystic fibrosis (nmCF): baseline data Journal of Cystic Fibrosis ·Eitan Kerem, M. Wilschanski, K. De Boeck, Isabelle Sermet‐Gaudelus, S. Constantine, Gary Elfring, N.L. Miller, Jay Barth, Temitayo Ajayi	2011	6
15	OP0006 Safety and efficacy of lenabasum (JBT-101) in diffuse cutaneous systemic sclerosis subjects treated for one year in an open-label extension of trial jbt101-ssc-001 Annals of the Rheumatic Diseases ·Robert Spiera, Laura K. Hummers, Leland W.K. Chung, Tracy Frech, Robyn T. Domsic, Vivien Hsu, D.E. Furst, Jessica Gordon, Maureen D. Mayes, Robert W. Simms, Eunyoung Lee, Nancy Dgetluck, S. Constantine, Barbara White	2018	6
16	610 Safety and efficacy of lenabasum in refractory skin-predominant dermatomyositis subjects treated on an open-label extension of trial JBT101-DM-001 Journal of Investigative Dermatology ·Victoria P. Werth, David R. Pearson, Joyce Okawa, Rui Feng, Josef Symon S. Concha, Basil Patel, Emily Z. Hejazi, C. Cornwall, S. Constantine, Barbara White	2019	5
17	605 Study of safety and efficacy of lenabasum, a cannabinoid receptor type 2 agonist, in refractory skin-predominant dermatomyositis Journal of Investigative Dermatology ·V. Werth, Emily Z. Hejazi, S.M. Peña, J Háber, Ruofei Feng, Basil Patel, Josef Symon S. Concha, S. Constantine, Barbara White	2018	5
18	Scleredema associated with immunoglobulin A-κ smoldering myeloma: a case report and review of the literature Journal of Medical Case Reports ·B. S. D. P. Keragala, H. M. M. T. B. Herath, G. H. D. C. Janappriya, B. S. Dissanayaka, S. C. Shyamini, D. P. Liyanagama, Thanushah Balendran, S. Constantine, C. N. Gunasekera	2019	5
19	WS7.3 Once-daily liposomal amikacin for inhalation is noninferior to twice-daily tobramycin inhalation solution in improving pulmonary function in cystic fibrosis patients with chronic infection due to Pseudomonas aeruginosa Journal of Cystic Fibrosis ·Diana Bilton, T. Pressler, Isabelle Fajac, J.P. Clancy, David Sands, P. Minic, Marco Cipolli, Mario La Rosa, Ivanka Galeva, Amparó Solé, Lieven Dupont, C. Goss, Nicole Mayer-Hamblett, Alexandra L. Quittner, S. Constantine, Renu Gupta, Michael W. Konstan	2014	5
20	OP0325 SAFETY AND EFFICACY OF LENABASUM IN AN OPEN-LABEL EXTENSION OF A PHASE 2 STUDY IN DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS SUBJECTS (DCSSC) Annals of the Rheumatic Diseases ·Robert Spiera, Laura K. Hummers, Leland W.K. Chung, Tracy Frech, Robin Domsic, Vivian Hsu, Daniel E. Furst, Jessica Gordon, Maureen D. Mayes, Robert W. Simms, Elizabeth Lee, S. Constantine, Nancy Dgetluck, Barbara White	2019	3

About S. Constantine

S. Constantine is a scholar working on Dermatology, Pulmonary and Respiratory Medicine, Epidemiology, Pathology and Forensic Medicine and Periodontics, having authored 27 papers that have together received 477 indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (7 papers), Inflammatory Myopathies and Dermatomyositis (7 papers), Systemic Sclerosis and Related Diseases (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Bipolar Disorder and Treatment (3 papers), Skin Diseases and Diabetes (3 papers), Inhalation and Respiratory Drug Delivery (3 papers) and Respiratory and Cough-Related Research (3 papers). The work is most often cited by research in Dermatology (59 citations), Pulmonary and Respiratory Medicine (201 citations), Pharmacology (99 citations), Pathology and Forensic Medicine (93 citations) and Genetics (36 citations). S. Constantine has collaborated with scholars based in United States, United Kingdom and Sri Lanka. Frequent co-authors include Barbara White, Nancy Dgetluck, Gary Elfring, Temitayo Ajayi, K. De Boeck, Isabelle Sermet‐Gaudelus, Samit Hirawat, A. Reha, Janine Fritsch and Delphine Roussel. Their work appears in journals such as Annals of the Rheumatic Diseases, Journal of Cystic Fibrosis, Journal of Investigative Dermatology, BMC Infectious Diseases and Arthritis & Rheumatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact